Financial Summary for the Third Quarter of the Fiscal Year Ending March 2026 [Japanese GAAP] (Consolidated)

Overview of Performance

In the consolidated cumulative third quarter period of the fiscal year ending March 2026, net sales amounted to 93,932 million yen (2.6% increase YoY), operating income was 8,999 million yen (5.0% increase YoY), ordinary income was 9,465 million yen (15.5% increase YoY), and net income attributable to owners of parent for the quarter was 6,348 million yen (24.1% increase YoY). In the Vision Care business, sales increased due to expansion of one-day disposable contact lens sales and the effect of price revisions, while operating income grew as increased investment costs such as preparation for the new factory operation and wage hikes were absorbed through appropriate control of selling, general and administrative expenses. The Other segment saw increased sales in the compost-related business but a sales decrease due to the contraction of the food business in China, resulting in an improvement in segment losses.

Financial Position and Outlook

Total assets were 193,910 million yen (up 6,319 million yen from the previous fiscal year-end), primarily reflecting an increase in fixed assets due to manufacturing equipment investment at the Malaysia factory. Liabilities were 99,873 million yen (down 1,587 million yen from the previous fiscal year-end), while net assets increased by 7,907 million yen to 94,037 million yen, raising the equity ratio to 48.1%. There is no change to the full-year earnings forecast for the fiscal year ending March 2026, with high progress due to expanded sales of one-day disposable contact lenses and foreign exchange gains. For the fourth quarter, cost recognition associated with the start of commercial production at the Malaysia factory and increased promotional expenses are expected, but the full-year forecast remains unchanged.